China NMPA Product Recall - Disposable integrated biopsy needle BARD® MARQUEE® Disposable Core Biopsy Instrument Kit

Bard Peripheral Vascular, Inc., through its affiliate Bard Medical Technology (Shanghai) Co., Ltd., has initiated a voluntary recall of its BARD® MARQUEE® Disposable Core Biopsy Instrument Kits. This recall, announced by the National Medical Products Administration (NMPA) on February 2, 2026, impacts specific product models registered under certificate numbers 20202140405 and 20202140429. The action is classified as a Level II recall, indicating a situation where the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. While the document confirms the voluntary nature of the recall by the company, it does not explicitly detail the specific violations or issues that prompted this action. The regulatory framework overseeing this event is the National Medical Products Administration of China, which published the recall information. The required action for the company involves the voluntary removal of the affected devices from the market, with comprehensive details regarding the specific models, specifications, and batches provided in the accompanying 'Medical Device Recall Event Report Form'.